Pro-resolving Lipid Mediator Reduces Amyloid-β42-induced Gene Expression in Human Monocyte-derived Microglia

Overview

Journal Neural Regen Res

Date 2024 Jun 18

PMID 38886959

Authors

Ying Wang

Xiang Zhang

Henrik Biverstal

Nicolas G Bazan

Shuai Tan

Nailin Li

Makiko Ohshima

Marianne Schultzberg

Xiaofei Li

Affiliations

Soon will be listed here.

Abstract

JOURNAL/nrgr/04.03/01300535-202503000-00031/figure1/v/2024-06-17T092413Z/r/image-tiff Specialized pro-resolving lipid mediators including maresin 1 mediate resolution but the levels of these are reduced in Alzheimer's disease brain, suggesting that they constitute a novel target for the treatment of Alzheimer's disease to prevent/stop inflammation and combat disease pathology. Therefore, it is important to clarify whether they counteract the expression of genes and proteins induced by amyloid-β. With this objective, we analyzed the relevance of human monocyte-derived microglia for in vitro modeling of neuroinflammation and its resolution in the context of Alzheimer's disease and investigated the pro-resolving bioactivity of maresin 1 on amyloid-β42-induced Alzheimer's disease-like inflammation. Analysis of RNA-sequencing data and secreted proteins in supernatants from the monocyte-derived microglia showed that the monocyte-derived microglia resembled Alzheimer's disease-like neuroinflammation in human brain microglia after incubation with amyloid-β42. Maresin 1 restored homeostasis by down-regulating inflammatory pathway related gene expression induced by amyloid-β42 in monocyte-derived microglia, protection of maresin 1 against the effects of amyloid-β42 is mediated by a re-balancing of inflammatory transcriptional networks in which modulation of gene transcription in the nuclear factor-kappa B pathway plays a major part. We pinpointed molecular targets that are associated with both neuroinflammation in Alzheimer's disease and therapeutic targets by maresin 1. In conclusion, monocyte-derived microglia represent a relevant in vitro microglial model for studies on Alzheimer's disease-like inflammation and drug response for individual patients. Maresin 1 ameliorates amyloid-β42-induced changes in several genes of importance in Alzheimer's disease, highlighting its potential as a therapeutic target for Alzheimer's disease.

References

Dyall S, Balas L, Bazan N, Brenna J, Chiang N, da Costa Souza F . Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions. Prog Lipid Res. 2022; 86:101165. PMC: 9346631. DOI: 10.1016/j.plipres.2022.101165. View

Etemad S, Zamin R, Ruitenberg M, Filgueira L . A novel in vitro human microglia model: characterization of human monocyte-derived microglia. J Neurosci Methods. 2012; 209(1):79-89. DOI: 10.1016/j.jneumeth.2012.05.025. View

Zhang Y, Sloan S, Clarke L, Caneda C, Plaza C, Blumenthal P . Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse. Neuron. 2015; 89(1):37-53. PMC: 4707064. DOI: 10.1016/j.neuron.2015.11.013. View

Robinson M, McCarthy D, Smyth G . edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009; 26(1):139-40. PMC: 2796818. DOI: 10.1093/bioinformatics/btp616. View

Colas R, Dalli J, Chiang N, Vlasakov I, Sanger J, Riley I . Identification and Actions of the Maresin 1 Metabolome in Infectious Inflammation. J Immunol. 2016; 197(11):4444-4452. PMC: 5127279. DOI: 10.4049/jimmunol.1600837. View

Naj A, Jun G, Beecham G, Wang L, Vardarajan B, Buros J . Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011; 43(5):436-41. PMC: 3090745. DOI: 10.1038/ng.801. View

Lambert J, Ibrahim-Verbaas C, Harold D, Naj A, Sims R, Bellenguez C . Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013; 45(12):1452-8. PMC: 3896259. DOI: 10.1038/ng.2802. View

Johnson E, Dammer E, Duong D, Ping L, Zhou M, Yin L . Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020; 26(5):769-780. PMC: 7405761. DOI: 10.1038/s41591-020-0815-6. View

Hamelin L, Lagarde J, Dorothee G, Leroy C, Labit M, Comley R . Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging. Brain. 2016; 139(Pt 4):1252-64. DOI: 10.1093/brain/aww017. View

10.

Emre C, Hjorth E, Bharani K, Carroll S, Granholm A, Schultzberg M . Receptors for pro-resolving mediators are increased in Alzheimer's disease brain. Brain Pathol. 2020; 30(3):614-640. PMC: 8018009. DOI: 10.1111/bpa.12812. View

11.

Rozemuller J, Eikelenboom P, STAM F . Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohistochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986; 51(3):247-54. DOI: 10.1007/BF02899034. View

12.

Holvoet P, Klocke B, Vanhaverbeke M, Menten R, Sinnaeve P, Raitoharju E . RNA-sequencing reveals that STRN, ZNF484 and WNK1 add to the value of mitochondrial MT-COI and COX10 as markers of unstable coronary artery disease. PLoS One. 2019; 14(12):e0225621. PMC: 6903720. DOI: 10.1371/journal.pone.0225621. View

13.

West P, McCorkindale A, Guennewig B, Ashhurst T, Viengkhou B, Hayashida E . The cytokines interleukin-6 and interferon-α induce distinct microglia phenotypes. J Neuroinflammation. 2022; 19(1):96. PMC: 9013466. DOI: 10.1186/s12974-022-02441-x. View

14.

Panigrahy D, Gilligan M, Serhan C, Kashfi K . Resolution of inflammation: An organizing principle in biology and medicine. Pharmacol Ther. 2021; 227:107879. DOI: 10.1016/j.pharmthera.2021.107879. View

15.

Smit T, Ormel P, Sluijs J, Hulshof L, Middeldorp J, de Witte L . Transcriptomic and functional analysis of Aβ oligomer-stimulated human monocyte-derived microglia-like cells. Brain Behav Immun. 2021; 100:219-230. DOI: 10.1016/j.bbi.2021.12.001. View

16.

Wang Y, Leppert A, Tan S, van der Gaag B, Li N, Schultzberg M . Maresin 1 attenuates pro-inflammatory activation induced by β-amyloid and stimulates its uptake. J Cell Mol Med. 2020; 25(1):434-447. PMC: 7810927. DOI: 10.1111/jcmm.16098. View

17.

Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J, Carrasquillo M . Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011; 43(5):429-35. PMC: 3084173. DOI: 10.1038/ng.803. View

18.

Wang C, Fan L, Khawaja R, Liu B, Zhan L, Kodama L . Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy. Nat Commun. 2022; 13(1):1969. PMC: 9005658. DOI: 10.1038/s41467-022-29552-6. View

19.

Lukiw W, Cui J, Marcheselli V, Bodker M, Botkjaer A, Gotlinger K . A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest. 2005; 115(10):2774-83. PMC: 1199531. DOI: 10.1172/JCI25420. View

20.

Do K, Hjorth E, Wang Y, Jun B, Kautzmann M, Ohshima M . Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer's Disease. Cell Mol Neurobiol. 2022; 43(2):797-811. PMC: 9957874. DOI: 10.1007/s10571-022-01216-5. View